Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
AIDS Research and Human Retroviruses|April 10, 2010
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis CEugenia Vispo, Pablo Labarga, Josep M Guardiola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patientsMarina Núñez, Ana Mariño, Angel Mariño, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 25, 2012
Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1bNorma I Rallón, Juan A Pineda, Vincent Soriano, et al.
AIDS (London, England)|November 11, 2021
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decadesJosé-Manuel Ramos-Rincon, Maroune Menchi-Elanzi, Héctor Pinargote-Celorio, et al.
Le Infezioni in Medicina|June 17, 2026
HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native populationVicente Soriano, María Del Carmen Nieto, Ana Belén Lozano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patientsJosé Medrano, Pablo Barreiro, Salvador Resino, et al.
Viruses|June 2, 2021
Social Restrictions versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish CaseFrancisco Javier Candel, Elisabet Viayna, Daniel Callejo, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 30, 2017
Diagnosis of cutaneous anthrax in resource-poor settings in West Arsi Province, EthiopiaRamón Pérez-Tanoira, Jose Manuel Ramos, Laura Prieto-Pérez, et al.
AIDS (London, England)|April 18, 2003
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patientsMayte Pérez-Olmeda, Marina Núñez, Miriam Romero, et al.
Journal of Hepatology|October 22, 2008
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patientsJuan Macías, Eva Recio, Eugenia Vispo, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
AIDS Research and Human Retroviruses|April 10, 2010
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis CEugenia Vispo, Pablo Labarga, Josep M Guardiola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patientsMarina Núñez, Ana Mariño, Angel Mariño, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 25, 2012
Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1bNorma I Rallón, Juan A Pineda, Vincent Soriano, et al.
AIDS (London, England)|November 11, 2021
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decadesJosé-Manuel Ramos-Rincon, Maroune Menchi-Elanzi, Héctor Pinargote-Celorio, et al.
Le Infezioni in Medicina|June 17, 2026
HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native populationVicente Soriano, María Del Carmen Nieto, Ana Belén Lozano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patientsJosé Medrano, Pablo Barreiro, Salvador Resino, et al.
Viruses|June 2, 2021
Social Restrictions versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish CaseFrancisco Javier Candel, Elisabet Viayna, Daniel Callejo, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 30, 2017
Diagnosis of cutaneous anthrax in resource-poor settings in West Arsi Province, EthiopiaRamón Pérez-Tanoira, Jose Manuel Ramos, Laura Prieto-Pérez, et al.
AIDS (London, England)|April 18, 2003
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patientsMayte Pérez-Olmeda, Marina Núñez, Miriam Romero, et al.
Journal of Hepatology|October 22, 2008
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patientsJuan Macías, Eva Recio, Eugenia Vispo, et al.
Pageof 22